123.Maiden L. A quantitative analysis of NSAID-induced small bowel pathology by capsule
enteroscopy / L. Maiden, B. Thjodleifsson, A. Theodors et al. // Gastroenterology. 2005. Vol. 128,
№ 5. – Р. 1172-1178.
124.Mandell B.F. COX-2 selective NSAIDs: biology, promises, and concerns / B.F. Mandell
// Cleve. Clin. J. Med. – 1999. - N66. – P. 285–292.
125.Matsumoto T. Endoscopic features of chronic nonspecific multiple ulcers of the small
intestine: comparison with nonsteroidal anti-inflammatory drug-induced enteropathy / T.
Matsumoto, S. Nakamura, M. Esaki et al. // Dig. Dis. Sci. – 2006. – Vol. 51, № 8. – Р. 1357-1363.
126.Matsumoto T. Non-specific multiple ulcers of the small intestine unrelated to non-
steroidal anti-inflammatory drugs / T. Matsumoto, M. Iida, T. Matsui et al. // J. Clin. Pathol. – 2004.
– Vol. 57,№ 11. – P. 1145-1150.
127.Melatonin protects against piroxicam-induced gastric ulceration / D. Bandyopadhyay, G.
Ghosh, A. Bandyopadhyay et al. // J. Pineal. Res.- 2004. –Vol. 36,№3. – Р. 195-203.
128.Meta-analysis: role of Helicobacter pylori eradication in the prevention of peptic ulcer in
NSAID users / M. Vergara, M. Catalan, J.P. Gisbert et al. // Aliment. Pharmacol. Ther. – 2005. –
Vol.21,№12. – Р.1411-1418.
129.Mohammed S. Gastropathy due to celexoxib, a cyclooxygenase-2 inhibitor / S.
Mohammed, D. Croom // N. Engl. J. Med. - l999. - №340. – P. 2005–2006.
130.Monocyte chemotactic protein-1 regulates leukocyte recruitment during gastric ulcer
recurrence induced by tumor necrosis factor-alpha / T. Watanabe, K. Higuchi, M. Hamaguchi et al.
// Am. J. Physiol. Gastrointest. Liver. Physiol. – 2004. – Vol. 287,№4. – Р. 919-928.
131.Morris A.J. Nonsteroidal anti-inflammatory drug enteropathy / A.J. Morris //
Gastrointest. Endosc. Clin. N. Am. – 1999. Vol. 9, № 1. – Р. 125-133.
132.Mort J.R. Interaction between selective serotonin reuptake inhibitors and nonsteroidal
antiinflammatory drugs: review of the literature / J.R. Mort, R.R. Aparasu, R.K. Baer //
Pharmacotherapy. – 2006. – Vol. 26, №9. – Р. 1307-1313.
133.Mousavi S. NSAIDs and Helicobacter pylori association in patients with bleeding peptic
ulcers / S. Mousavi, J. Toussy, M. Zahmatkesh // Indian. J. Gastroenterol. –2006. – Vol. 25, №4. –
Р. 216.
134.Mucosal damage induced by preferential COX-1 and COX-2 inhibitors: role of
prostaglandins and inflammatory response / I. Villegas, C. La Casa, C.A. de la Lastra et al. // Life
Sci. – 2004. – Vol.74,№7. – Р. 873-884.
135.Muniappan M. Antiinflammatory and antiulcer activities of Bambusa arundinacea / M.
Muniappan, T. Sundararaj // J. Ethnopharmacol. – 2003. – Vol.88,№2-3. – Р. 161-167.
136.Neutrophils, Helicobacter pylori, and nonsteroidal anti-inflammatory drug ulcers / A.S.
Taha, S. Dahill, C. Morran et al. // Gastroenterology. – 1999. –Vol. 116. – P. 254–258.
137.New amides and gastroprotective constituents from the fruit of Piper chaba / T.
Morikawa, H. Matsuda, I. Yamaguchi et al. // Planta Med. – 2004. – Vol.70,№2. - Р.152-159.
138.Nitric oxide-releasing aspirin protects gastric mucosa against ethanol damage in rats
with functional ablation of sensory nerves / P.C. Konturek, T. Brzozowski, J. Kania et al. //
Inflamm. Res. – 2003. – Vol. 52,№9. – Р. 359-365.
139.Non-steroidal anti-inflammatory drug use and the risk of gastric cancer: a systematic
review and meta-analysis / W.H. Wang, J.Q. Huang, G.F. Zheng et al. // J. Natl. Cancer. Inst. –
2003. – Vol.95,№23. – Р. 1784-1791.
140.Non-steroidal anti-inflammatory drug-induced small bowel injuries identified by double-
balloon endoscopy / Y. Hayashi, H. Yamamoto, H. Kita et al. // World. J. Gastroenterol. – 2005. –
Vol. 11,№31. – Р. 4861-4864.
141.NSAID-associated dyspepsia and ulcers: a prospective cohort study in primary care / M.
Hollenz, M. Stolte, A. Leodolter, J. Labenz // Dig. Dis. – 2006. – Vol. 24, №1-2. – Р. 189-194.